Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
01/1990
01/30/1990CA1265132A1 Process for the organic synthesis of oligosaccharides and derivatives thereof
01/30/1990CA1265131A1 Derivatives of erythromycylamine
01/30/1990CA1265130A1 Process of selectively blocking amino groups
01/30/1990CA1265129A1 Pyranoderivatives, their preparation and therapeutic compositions containing the same
01/30/1990CA1265061A1 Alkyl glycosides as potentiating agents in antiseptic, disinfecting and cleaning preparations to increase microbicidal activity
01/30/1990CA1265060A1 Polyisobutilene containing sunscreen compound, and its use for protecting the skin of humans against harmful ultraviolet radiation
01/30/1990CA1265058A1 Tinctorial composition containing 5-nitrovanillin
01/30/1990CA1265057A1 Ophthalmic topical agent for remedy of diseases of iris and ciliary body
01/30/1990CA1265056A1 Method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same
01/30/1990CA1265055A1 Pharmaceutical preparation
01/30/1990CA1265052A1 Absorption enhancing agents
01/30/1990CA1265009A1 Initiating reperfusion treatment when heart attack symptoms are present
01/25/1990WO1990000598A1 Purification and administration of dna repair enzymes
01/25/1990WO1990000596A1 Method of modulating virus-host cell interactions using carbohydrates and carbohydrate derivatives
01/25/1990WO1990000559A1 New androstane derivatives
01/25/1990WO1990000555A1 Lipid derivatives of antiviral nucleosides, liposomal incorporation and method of use
01/25/1990WO1990000553A1 Rifapentine hydrohalides
01/25/1990WO1990000549A1 Immunosuppressive agents
01/25/1990WO1990000548A2 Derivatized alkanolamines as cardiovascular agents
01/25/1990WO1990000541A1 Novel cyclopentano-vitamin d analogs
01/25/1990WO1990000540A1 The use of vitamin d metabolites or analogues for the prevention of graft rejection
01/25/1990WO1990000407A1 Oxazolidinone penetration enhancing compounds
01/25/1990WO1990000406A1 Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon
01/25/1990WO1990000394A1 Natriuretic hormone
01/25/1990WO1990000393A1 Topical hematoporphyrin
01/25/1990WO1990000392A1 Purified hematoporphyrin dimers and trimers useful in photodynamic therapy
01/25/1990WO1990000391A1 Depot-form of an alginate-based drug
01/25/1990WO1990000390A1 New synergistic preparations containing dezocine and a local anaesthetic and a new method of alleviation of pain
01/25/1990DE3824669A1 Composition for preventing infection with HIV
01/24/1990EP0352249A1 Novel platelet-aggregation inhibitors
01/24/1990EP0352198A2 5-methoxypsoralen and other furocoumarins as jet lag suppressants
01/24/1990EP0352147A2 Use of naringine, naringenine or their derivatives in the manufacture of an anticancer composition
01/24/1990EP0352025A2 Use of nalmefene in the treatment of allergic rhinitis
01/24/1990EP0352013A2 Hydroxymethyl cyclobutyl purines
01/24/1990EP0352005A2 Antiulcer (alkyldithio) quinoline derivatives
01/24/1990EP0351987A1 Use of polymeric compounds in treatment
01/24/1990EP0351974A1 Treatment of genital warts with a combination of podophyllin and recombinant DNA human alpha interferon
01/24/1990EP0351958A1 Compounds and pharmaceutical preparations useful in reduction of the severity of 3'-azido-3'-deoxythymidine-induced anaemia
01/24/1990EP0351923A2 Alkyl avermectin derivatives
01/24/1990EP0351918A1 Process for the lactonization of mevinic acids and analogs thereof
01/24/1990EP0351897A2 Skin penetration system for salts of amine-functional drugs
01/24/1990EP0351889A1 Process for the preparation of a quinoline carboxylic acid
01/24/1990EP0351887A1 Tricyclic aromatic compounds
01/24/1990EP0351885A1 Use of pentoxifyllin in treating inflammatory diseases
01/24/1990EP0351865A2 DC-89 compounds and process for their preparation
01/24/1990EP0351856A2 Thiazolo[5,4-b]azepine compounds
01/24/1990EP0351828A2 Antimicrobial antifoam compositions
01/24/1990EP0351809A2 Blood anticoagulant
01/24/1990EP0351799A2 Antifungal antibiotics
01/24/1990EP0351795A2 Novel deoxyadenosine compounds and methods of making and using the same
01/24/1990EP0351784A2 Therapeutic use of the isopropyl ester derivative of monosialoganglioside in nervous pathologies with an inflammatory component
01/24/1990EP0351767A2 Use of potassium channel activators to inhibit myocardial cell necrosis and to maintain the functioning of the heart during myocardial ischemia and/or reperfusion
01/24/1990EP0351755A1 Combination of a calcium channel blocker and thromboxane A2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination
01/24/1990EP0351733A1 Use of 2,3,4,5-tetrahydro-1H-3-benzazepines in the treatment of neurological disorders
01/24/1990EP0351720A2 Use of substituted 3,4-dihydro-2H-benzopyrans as medicaments against obstructive disorders of the lung
01/24/1990EP0351698A1 Synergistic pharmaceutical composition with an antimicrobial action and process for preparing same
01/24/1990EP0351696A2 Allylaminoethylazoles
01/24/1990EP0351625A1 Anti-HIV activity of BV-3608
01/24/1990EP0351561A1 Novel esters of estramustine
01/24/1990EP0351435A1 Fused pyridazine compounds and their medicinal uses
01/24/1990CN1039028A Process for preparing compounds
01/24/1990CN1039026A Process for preparing tricyclic 3-oxo-propanenitrile derivatives
01/24/1990CN1039024A Pseudo-primvcin complexes, components and acid addition salts thereof as well as process for preparing same
01/24/1990CN1039016A Anthelmintic n'-substituted-n, n'disubstitutedhydrazines
01/24/1990CN1006549B Method for preparing aromatic sulphones compounds
01/24/1990CN1006548B Improvements in or relating to benzenesul fonamido derivatives
01/23/1990US4895963 1,3-Dioxan-5-yl-hexenoic acids
01/23/1990US4895962 Thromboxane a2 antagonists
01/23/1990US4895956 3-aroyl-6,7-dihydro-5H-pyrrolo(1,2-c)imidazole-7-carboxylic acid derivatives
01/23/1990US4895946 Process for the preparation of fused pyridine compounds
01/23/1990US4895933 New antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin
01/23/1990US4895876 Artificial blood, organ preservation
01/23/1990US4895875 Succinic anhydride
01/23/1990US4895874 Tumor treatment process and composition
01/23/1990US4895873 Calcium salt of valproic acid
01/23/1990US4895872 Treating hyperactive immune systems; autoimmune and graft/host diseases
01/23/1990US4895870 Urogenital, antibiotic
01/23/1990US4895868 Thiochroman esters of phenols and terephthallates having retinoid-like activity
01/23/1990US4895866 Anti-inflammatory imidazole compounds
01/23/1990US4895863 Memory disorders
01/23/1990US4895861 Novel naphthalenyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents
01/23/1990US4895859 Anti-infective methods and compositions
01/23/1990US4895857 Anti-infective methods and compositions
01/23/1990US4895856 Derivatives of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4-oxobutanoic acids with antagonistic activity towards cholecystokinin
01/23/1990US4895855 Mixture of different dihydropyridines
01/23/1990US4895853 Antitumor alkaloids
01/23/1990US4895851 Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
01/23/1990US4895848 Treatment of alcoholism using 2-pyrimidinyl-1-piperazine derivative
01/23/1990US4895845 Reserpine and trazodone, bupropion or fluoxetine antidepressant
01/23/1990US4895843 Use of 3-(4-bromo-2-fluorobenzyl)-4-oxo-3H-phthalazin-1-ylacetic acid as a hypouricaemic agent
01/23/1990US4895841 Cyclic amine compounds with activity against acetylcholinesterase
01/23/1990US4895840 Antiarrhythmia agents
01/23/1990US4895839 Pharmaceutical and cosmetic compositions containing complexes of flavanolignans with phospholipids
01/23/1990US4895838 Method for provoking angiogenesis by administration of angiogenically active oligosaccharides
01/23/1990US4895837 Avermectin derivatives
01/23/1990US4895836 Nor-cholanic acid derivatives, a process for their preparation, their use and pharmaceutical compositions containing them
01/23/1990US4895727 Pharmaceutical vehicles for exhancing penetration and retention in the skin
01/23/1990US4895726 Anticholesterol, antilipemic, micronized with surfactant
01/23/1990US4895723 Anticholesterol, odorless, sugar-carbohydrate syrup, orally ingestible
01/23/1990US4895719 Suspension, encapsulation, drug delivery